What is ATXS's current stock price?

ATXS (Astria Therapeutics, Inc.) is currently trading at $12.58 with a market cap of $718.1M.

What sector is Astria Therapeutics, Inc. in?

Astria Therapeutics, Inc. (ATXS) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

ATXS Astria Therapeutics, Inc.

NASDAQHealthcare

$12.58+0.00%ClosedMarket Cap: $718.1M

As of 2026-01-23 16:00

Why ATXS matters now

Astria Therapeutics, Inc. (ATXS) is a US stock in Healthcare. The latest InvestLog snapshot shows $12.58 with +0.00% on the session and $718.1M in market capitalization.

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.02

Astria Therapeutics, Inc. is a biopharmaceutical company based in Boston, Massachusetts, established in 2008. The firm specializes in identifying, advancing, and bringing to market treatments for uncommon and specialized allergic and immunological disorders across the United States. Its leading experimental drug, STAR-0215, is a monoclonal antibody that targets and inhibits plasma kallikrein. This candidate is presently undergoing preclinical development to address hereditary angioedema. The company adopted its current name, Astria Therapeutics, Inc., in September 2021, having previously operated as Catabasis Pharmaceuticals, Inc.